“…In previous reports, it has been demonstrated that EOs can exert either antibacterial [ 15 , 17 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 ] or biofilm modulation effects [ 15 , 16 , 17 , 20 , 42 , 43 , 44 , 45 , 46 , 47 , 48 ]. As a continuation of a previously reported screen for antibacterial and antibiofilm EOs [ 15 , 16 , 17 , 20 , 42 ], herein, 61 previously investigated commercial samples have been evaluated for their abilities to modulate the biofilm formation of six P. aeruginosa clinical strains (22P, 25P, 26P, 27P, 37P, and 39P) in comparison with the reference strains PAO1 and PA14.…”